Action Potential Venture Capital (APVC) is an independent corporate venture arm of GlaxoSmithKline (GSK) that invests globally in companies developing bioelectronic medicines. This emerging field includes both non-invasive and minimally invasive therapeutic devices that stimulate or block nerve signaling to regulate organ function implicated in chronic diseases. APVC also invests in the enabling technologies that deliver this precision energy as a medicine.
Applied Ventures, LLC, the venture capital arm of Applied Materials, invests in early-stage technology companies that promise to deliver high growth and exceptional returns. The company offers startups access to new materials engineering and semiconductor technology innovations.
As a global investment manager and fiduciary to their clients, BlackRock’s purpose is to help everyone experience financial well-being. Since 1999, BlackRock has been a leading provider of financial technology, and their clients turn to them for the solutions they need when planning for their most important goals.
BOLD manages a family of funds targeting investments in early stage and growth technology companies. BOLD is particularly interested in entrepreneurial leaders that leverage exponential technologies to transform the world and create innovative solutions to humanity’s grand challenges.
Compal is a worldwide leading 5C products manufacturer. Compal invests in the product innovation and technologies and intergrade them into IoT applications to create various smart solutions. Compal is in the business of collaborative innovation and making ideas happen to bring their clients from vision to reality.
Creative Ventures is a U.S.-based venture capital firm investing in startups using deep technology to address global secular trends in traditional sectors.
Ferretto Capital is a professionally-run family office that focuses on generating consistent long-term returns by allocating to a globally diversified portfolio of funds, with a focus on alternatives. With a team of experienced fund managers and allocators, they combine a process-driven, institutional investment approach with the nimbleness of a family office.
Fiscus Ventures and Reimagined Ventures (Affiliates of Magnetar Capital) looks to support innovative groundbreaking technologies that will both change the delivery and practice of clinical medicine.
HM Capital Management is a fee-only Registered Investment Advisor serving as a legal fiduciary to affluent families and Institutional Clients. HM Capital’s mission is to be problem solvers, a source of solutions and the go-to person for all things financial.
Intel Capital invests in innovative startups targeting artificial intelligence, autonomous technology, data center and cloud, 5G, next-generation compute, and a wide range of other disruptive technologies. Since 1991, Intel Capital has invested US$12.5 billion in more than 1,550 companies worldwide.
Longevity Vision Fund, a new venture capital fund focused on early-stage technologies and life science businesses. The Fund seeks to invest in companies that provide products, services, and technologies aimed to extend the period of healthy human life.
Nautilus Venture Partners invests in early-stage companies with unique technology, a strong team, and market potential. Our focus includes artificial intelligence, IoT, and mobile.
OSF Ventures specializes in venture optimization, partnering financially and operationally in companies that improve patient outcomes and reduce costs to health care systems. OSF Ventures is a division of OSF HealthCare.
Pura Vida Investments, LLC (“Pura Vida”) is a fundamentally-driven investment manager focusing on innovative and disruptive technologies, company life cycle changes, and structural shifts in the healthcare landscape. Pura Vida invests across all facets of healthcare, particularly companies that develop, produce, and commercialize innovative medical technology, diagnostics tests, genomic instruments, and bio-therapeutics.
RA Capital Management, located in Boston, Massachusetts, is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices and diagnostics.
Rising Tide is focused on early stage investments in startups with unique value propositions in promising vertical markets including artificial intelligence, blockchain, cleantech, digital communications, enterprise software, health care, fintech, and smart mobility. Rising Tide is actively collaborating with the ecosystem of innovation in Canada and Silicon Valley - including universities, accelerators, and corporate partners – to identify and invest in the most promising startups with double bottom line impact: value creation and human impact. The Team’s main focus is on helping entrepreneurs in corporate governance, human capital development, business expansion, and global strategic partnerships.
Sands Capital is an active, long-term investor in leading innovative businesses globally. The firm’s approach combines rigorous fundamental analysis with creative thinking to identify high-quality growth businesses that are creating the future.
Solasta Ventures (formerly known in the U.S. as Aju IB Investment) is the US arm of Aju IB Investment, one of the most established venture capital firms in South Korea with over $1.5 billion in AUM. Solasta Ventures invests in innovative companies in life sciences and therapeutics as well as deep technology companies solving difficult problems.
Sony Innovation Fund is a segment of Sony Corporation that assists the growth of tech startups. Sony Innovation Fund is dedicated to engaging with promising early-stage companies. Beyond investment, its mission is to provide access to the broader Sony world and its global network.
TDK Ventures is a technology-focused venture fund, investing globally in early-stage startups that leverages fundamental material science to unlock an attractive and sustainable future for the world. TDK Ventures’ goal is to help every start-up we invest to achieve their full potential for positive world impact.
Wanxiang Healthcare Investments is an early-stage venture capital group focusing on investments in the digital health space. WHI seeks to invest in companies that enable the decentralization of the delivery of healthcare, leading to improved outcomes and lower costs. Wanxiang Healthcare Investments is a division of Wanxiang America Corporation.
For more than 50 years, Wilson Sonsini Goodrich & Rosati (WSGR) has offered a broad range of services and legal disciplines focused on serving the principal challenges faced by the management and boards of directors of business enterprises.